The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study - PubMed (original) (raw)
. 1999 Jun;26(6):1326-32.
Affiliations
- PMID: 10381051
The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study
M A González-Gay et al. J Rheumatol. 1999 Jun.
Abstract
Objective: To examine patients presenting with polymyalgia rheumatica (PMR) during a 10 year period in Northwestern Spain and to assess disease incidence and the frequency of relapses in patients diagnosed as having either isolated ("pure") PMR or PMR associated with giant cell arteritis (GCA).
Methods: Clinical records of patients with PMR diagnosed at the Hospital Xeral Lugo from January 1987 through December 1996 were reviewed. Patients with PMR were categorized into 2 subgroups depending on the presence or absence of associated GCA. Other conditions presenting with polymyalgia symptoms or mimicking isolated PMR were excluded. These patients were followed from the time of diagnosis until either patient's death or January 1, 1998.
Results: One hundred eighty-five patients were studied. The average annual incidence rates of the total group of PMR and isolated PMR were 18.67 x 10(-5) and 13.52 x 10(-5), respectively, in a population aged 50 years or older. Relapses were frequent in both isolated PMR and PMR associated with GCA. In general, they occurred when the dose of prednisone was < 7.5 mg/day or it had been discontinued. Rate of steroid tapering was significantly higher in patients with isolated PMR who had relapses. Patients with HLA-DRB1*0401 had a higher frequency of relapses. As reported in patients with PMR associated with GCA, the adjusted mortality rate in patients with isolated PMR showed no difference compared to the Spanish population aged 50 years or older.
Conclusion: In Northwestern Spain, PMR is a nonfatal disease with a low incidence and frequent relapses. A possible influence of HLA-DRB1*04 alleles in the development of more severe disease, with greater tendency to relapses, is suggested.
Similar articles
- The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain.
Gonzalez-Gay MA, Garcia-Porrua C, Salvarani C, Olivieri I, Hunder GG. Gonzalez-Gay MA, et al. J Rheumatol. 2000 Sep;27(9):2179-84. J Rheumatol. 2000. PMID: 10990231 - Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms.
Mattey DL, Hajeer AH, Dababneh A, Thomson W, González-Gay MA, García-Porrúa C, Ollier WE. Mattey DL, et al. Arthritis Rheum. 2000 Aug;43(8):1749-55. doi: 10.1002/1529-0131(200008)43:8<1749::AID-ANR11>3.0.CO;2-K. Arthritis Rheum. 2000. PMID: 10943865 - Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica.
González-Gay MA, Amoli MM, Garcia-Porrua C, Ollier WE. González-Gay MA, et al. Semin Arthritis Rheum. 2003 Aug;33(1):38-48. doi: 10.1053/sarh.2002.50025. Semin Arthritis Rheum. 2003. PMID: 12920695 Review. - [Polymyalgia rheumatica and temporal arteritis].
Vos PA, Bijlsma JW, Derksen RH. Vos PA, et al. Ned Tijdschr Geneeskd. 2005 Aug 27;149(35):1932-7. Ned Tijdschr Geneeskd. 2005. PMID: 16159030 Review. Dutch.
Cited by
- Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001.
Smeeth L, Cook C, Hall AJ. Smeeth L, et al. Ann Rheum Dis. 2006 Aug;65(8):1093-8. doi: 10.1136/ard.2005.046912. Epub 2006 Jan 13. Ann Rheum Dis. 2006. PMID: 16414971 Free PMC article. - Polymyalgia rheumatica.
Michet CJ, Matteson EL. Michet CJ, et al. BMJ. 2008 Apr 5;336(7647):765-9. doi: 10.1136/bmj.39514.653588.80. BMJ. 2008. PMID: 18390527 Free PMC article. Review. No abstract available. - Incidence and Prevalence of Polymyalgia Rheumatica (PMR): The Importance of the Epidemiological Context. The Italian Case.
Manzo C. Manzo C. Med Sci (Basel). 2019 Aug 30;7(9):92. doi: 10.3390/medsci7090092. Med Sci (Basel). 2019. PMID: 31480261 Free PMC article. - Effectiveness of methotrexate and leflunomide as corticoid-sparing drugs in patients with polymyalgia rheumatica.
Vinicki JP, Cusa A, Domingo D, Velasco Zamora JL, Magri S, Brigante A, Schmid MM, Ávila P, Zamora N, Sorrentino L, Rodriguez AM, Linarez M, Pisoni C, Costi C, Rodriguez Gil G, Spinetto MA, Paris VU, Perrotta N, Maliandi MDR, Rillo O, Pena C, Got J, Cavallasca J, Machado Escobar M, Iturralde C, Martire MV, Tessel R, Chocobar NS, Alarcon G. Vinicki JP, et al. Rheumatol Adv Pract. 2024 Mar 21;8(2):rkae033. doi: 10.1093/rap/rkae033. eCollection 2024. Rheumatol Adv Pract. 2024. PMID: 38560643 Free PMC article. - Clinical guidelines: Best practices and uncertainties in the management of PMR.
González-Gay MA, Llorca J. González-Gay MA, et al. Nat Rev Rheumatol. 2016 Jan;12(1):3-4. doi: 10.1038/nrrheum.2015.142. Epub 2015 Oct 20. Nat Rev Rheumatol. 2016. PMID: 26481433 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials